Miguel Angel Perez-Castro

Dr. Miguel Angel Perez-Castro

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2019 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
HEHasier Eraña
Hasier Eraña
JCJorge M Charco
Jorge M Charco
MBMichele Angelo Di Bari
Michele Angelo Di Bari
CDCarlos M Díaz-Domínguez
Carlos M Díaz-Domínguez
RLRafael López-Moreno
Rafael López-Moreno
Joaquín CastillaJoaquín Castilla
Joaquín Castilla
The resolution of the three-dimensional structure of infectious prions at the atomic level is pivotal to understand the pathobiology of Transmissible Spongiform Encephalopathies (TSE), but has been long hindered due to certain particularities of these proteinaceous pathogens. Difficulties related to their purification from brain homogenates of disease-affected animals were resolved almost a decade ago by the development of in vitro recombinant prion propagation systems giving rise to highly infectious recombinant prions. However, lack of knowledge about the molecular mechanisms of the misfolding event and the complexity of systems such as the Protein Misfolding Cyclic Amplification (PMCA), have limited generating the large amounts of homogeneous recombinant prion preparations required for high-resolution techniques such as solid state Nuclear Magnetic Resonance (ssNMR) imaging. Herein, we present a novel recombinant prion propagation system based on PMCA that substitutes sonication with shaking thereby allowing the production of unprecedented amounts of multi-labeled, infectious recombinant prions. The use of specific cofactors, such as dextran sulfate, limit the structural heterogeneity of the in vitro propagated prions and makes possible, for the first time, the generation of infectious and likely homogeneous samples in sufficient quantities for studies with high-resolution structural techniques as demonstrated by the preliminary ssNMR spectrum presented here. Overall, we consider that this new method named Protein Misfolding Shaking Amplification (PMSA), opens new avenues to finally elucidate the three-dimensional structure of infectious prions. Prion disorders are a group of devastating neurodegenerative diseases caused by an aberrantly folded isoform of the endogenous prion protein. The molecular mechanisms by which this proteinaceous pathogen is able to propagate in the central nervous system and cause neuronal death are poorly understood, partially due to the difficulties elucidating the three-dimensional structure of the aggregation-prone aberrant isoform or prion. Obtaining sufficient amounts of highly pure and homogeneous prions for high-resolution structural studies has been limited until now due to technical reasons. Here, we present a novel method for the production of large amounts of highly infectious recombinant prions suitable for solid state Nuclear Magnetic Resonance imaging, which could help to unveil the molecular pathogenesis of these particular pathogens.

8 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HEHasier Eraña
Hasier Eraña
CSCristina Sampedro-Torres-Quevedo
Cristina Sampedro-Torres-Quevedo
JCJorge M. Charco
Jorge M. Charco
CDCarlos M. Díaz-Domínguez
Carlos M. Díaz-Domínguez
FPFrancesca Peccati
Francesca Peccati
Joaquín CastillaJoaquín Castilla
Joaquín Castilla
Prion diseases are a group of rapidly progressing neurodegenerative disorders caused by the misfolding of the endogenous prion protein (PrPC) into a pathogenic form (PrPSc). This process, despite being the central event underlying these disorders, remains largely unknown at a molecular level, precluding the prediction of new potential outbreaks or interspecies transmission incidents. In this work, we present a method to generate bona fide recombinant prions de novo, allowing a comprehensive analysis of protein misfolding across a wide range of prion proteins from mammalian species. We study more than 380 different prion proteins from mammals and classify them according to their spontaneous misfolding propensity and their conformational variability. This study aims to address fundamental questions in the prion research field such as defining infectivity determinants, interspecies transmission barriers or the structural influence of specific amino acids and provide invaluable information for future diagnosis and therapy applications.

30 March 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SBSARA BACHILLER
SARA BACHILLER
MRMaría Angustias Roca-Ceballos
María Angustias Roca-Ceballos
Irene García DomínguezIrene García Domínguez
Irene García Domínguez
EPEva María Pérez-Villegas
Eva María Pérez-Villegas
DMDavid Martos-Carmona
David Martos-Carmona
RLRocío Ruiz Laza
Rocío Ruiz Laza

14 December 2017 in Pathogens
Verified
Journal Article
Open access
PDF file
JCJorge M. Charco
Jorge M. Charco
HEHasier Eraña
Hasier Eraña
VVVanessa Venegas
Vanessa Venegas
SGSandra García-Martínez
Sandra García-Martínez
RLRafael López-Moreno
Rafael López-Moreno
Joaquín CastillaJoaquín Castilla
Joaquín Castilla
The misfolding of the cellular prion protein (PrPC) into the disease-associated isoform (PrPSc) and its accumulation as amyloid fibrils in the central nervous system is one of the central events in transmissible spongiform encephalopathies (TSEs). Due to the proteinaceous nature of the causal agent the molecular mechanisms of misfolding, interspecies transmission, neurotoxicity and strain phenomenon remain mostly ill-defined or unknown. Significant advances were made using in vivo and in cellula models, but the limitations of these, primarily due to their inherent complexity and the small amounts of PrPSc that can be obtained, gave rise to the necessity of new model systems. The production of recombinant PrP using E. coli and subsequent induction of misfolding to the aberrant isoform using different techniques paved the way for the development of cell-free systems that complement the previous models. The generation of the first infectious recombinant prion proteins with identical properties of brain-derived PrPSc increased the value of cell-free systems for research on TSEs. The versatility and ease of implementation of these models have made them invaluable for the study of the molecular mechanisms of prion formation and propagation, and have enabled improvements in diagnosis, high-throughput screening of putative anti-prion compounds and the design of novel therapeutic strategies. Here, we provide an overview of the resultant advances in the prion field due to the development of recombinant PrP and its use in cell-free systems.

19 March 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
HEHasier Eraña
Hasier Eraña
JCJorge M. Charco
Jorge M. Charco
EGEzequiel González-Miranda
Ezequiel González-Miranda
SGSandra García-Martínez
Sandra García-Martínez
RLRafael López-Moreno
Rafael López-Moreno
Joaquín CastillaJoaquín Castilla
Joaquín Castilla
Transmissible spongiform encephalopathies or prion diseases are rapidly progressive neurodegenerative diseases, the clinical manifestation of which can resemble other promptly evolving neurological maladies. Therefore, the unequivocal ante-mortem diagnosis is highly challenging and was only possible by histopathological and immunohistochemical analysis of the brain at necropsy. Although surrogate biomarkers of neurological damage have become invaluable to complement clinical data and provide more accurate diagnostics at early stages, other neurodegenerative diseases show similar alterations hindering the differential diagnosis. To solve that, the detection of the pathognomonic biomarker of disease, PrPSc, the aberrantly folded isoform of the prion protein, could be used. However, the amounts in easily accessible tissues or body fluids at pre-clinical or early clinical stages are extremely low for the standard detection methods. The solution comes from the recent development of in vitro prion propagation techniques, such as Protein Misfolding Cyclic Amplification (PMCA) and Real Time-Quaking Induced Conversion (RT-QuIC), which have been already applied to detect minute amounts of PrPSc in different matrixes and make early diagnosis of prion diseases feasible in a near future. Herein, the most relevant tissues and body fluids in which PrPSc has been detected in animals and humans are being reviewed, especially those in which cell-free prion propagation systems have been used with diagnostic purposes.

8 July 2026 in Nature
Verified
Journal Article
Closed access
PDF file
KAKhalid N. Al-Zahrani
Khalid N. Al-Zahrani
ELEllen R. Langille
Ellen R. Langille
JNJocelyn Nurtanto
Jocelyn Nurtanto
AOAndreea Obersterescu
Andreea Obersterescu
KTKatie Teng
Katie Teng
DSDaniel Schramek
Daniel Schramek